American International (AIG) was downgraded from hold to sell, Deutsche Bank said. The stock has a $61 price target. The loss of Peter Hancock is a negative.
Boeing (BA) was downgraded from overweight to equal-weight, Morgan Stanley said. The stock has a $190 price target. This was a valuation call, as the stock is up 15% year-to-date.
Bioverativ (BIVV) was downgraded from buy to neutral, Goldman Sachs said. It has a $55 price target. The company is facing increased competition.
Blueprint Medicines (BPMC) was upgraded from neutral to buy, Goldman Sachs said. It has a $52 price target. The company has strong pipeline momentum.
Rockwell Collins (COL) was upgraded to overweight, Morgan Stanley said. It has a $121 price target. The BEAV acquisition could add as much as 30% to earnings.
Gartner (IT) was upgraded to top pick, Goldman Sachs said. It has a $124 price target. The CEB acquisition can drive growth over the next several quarters.
Johnson Controls (JCI) was downgraded from buy to neutral, Goldman Sachs said. It has a $44 price target. Analysts see a limited downside to synergy targets.
This article was written by a staff member of TheStreet.